Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
CVS Health has made a move ... AbbVie's Humira (adalimumab) recently approved as Hyrimoz. A new version is set for launch in the US under a Cordavis label in early 2024 at an 80% discount to ...
March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ...
Yet her speech raised a markedly un-sexy issue: health insurance accessibility for recording artists. “Record labels need to treat their artists as valuable employees with a livable wage and ...
ANI Pharmaceuticals plans to begin marketing the expanded label later this year. Perspective from Andrew A. Moshfeghi, MD, MBA The FDA approved an expanded label for Iluvien, which is now ...
BioMarin's Phase 3 trial shows Palynziq significantly reduces blood Phe in adolescents with PKU. The company plans a ...
The three benchmarks were FDA approval alone, FDA approval plus NCCN off-label recommendations ... McGill University School of Population and Global Health, Montréal, Québec, Canada, was ...
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval for Uplizna, now approved as a treatment for immunoglobulin G4-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback